Skip to main content
Premium Trial:

Request an Annual Quote

Gate-Crashing is a Good Time

Navigenics has launched, adding its services to the other personal genome companies, 23andMe and DeCodeMe. At Wired's blog, Thomas Goetz describes how Navigenics' service differs from the others. Navigenics is using a 1 million SNP chip but only lets its users see results for 18 diseases thus far — they will keep testing members' DNA as more associations are validated. The initial cost is $2,500 and then a yearly $250 fee.

If you are near SoHo, here's the calendar of events. No word on whether that's an open bar tonight.


The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.